Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphate contains galactosamine and D-chiroinositol
- PMID: 2833261
- DOI: 10.1016/s0006-291x(88)80520-5
Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphate contains galactosamine and D-chiroinositol
Abstract
It has been established that insulin treatment of cells, isolated plasma membranes, or whole animals leads to the generation of low molecular weight mediators which serve as intermediates in the signalling pathway. At least two distinct classes of mediator have been described, based on differences in apparent molecular weight, isoelectric point and biological activity (Cheng, K., and Larner, J. (1985) Ann. Rev. Physiol. 45, 407-424). Recently, Saltiel's (Saltiel, A.R., and Cuatrecasas, P. (1986) Proc. Natl. Acad. Sci. U.S.A. 83, 5793-5797) and Mato's (Mato, J.M., Kelly, K.L., Abler, A., and Jarett, L. (1987) J. Biol. Chem. 262, 2131-2137) laboratories have described an insulin "modulator" which was apparently derived from glycosylphosphoinositol linker, similar to those known to anchor proteins to the external surface of the cell membrane (Low, M.G. (1987) Bioch. J. 244, 1-13). In this paper, we report that highly purified preparations of the insulin mediator which stimulates pyruvate dehydrogenase phosphatase contain mannose, galactosamine, and D-chiroinositol. These determinations are based upon analyses using paper chromatography and gas chromatography/mass spectroscopy. Nitrous acid deamination of the mediator resulted in release of inositol phosphate, indicating that the galactosamine and D-chiroinositol are linked. Although the presence of chiroinositol in modulator from H35 hepatoma cells has been recently reported (Mato, J.M., Kelly, K.L., Abler, A., Jarett, L., Corkey, B.E., Cashel, J.A., and Zopf, D. (1987) Bioch. Biophys. Res. Comm. 146, 764-770), the optical identity of the inositol remained unknown until the present report. Likewise, the presence of galactosamine rather than glucosamine in insulin mediator is a novel finding. These findings, coupled with those of Saltiel and Mato's groups, provide clear evidence for the existence of multiple forms of insulin mediators. Additionally, the results presented here afford further confirmation for the formation of insulin mediators from glycosyl-phosphoinositol linkers.
Similar articles
-
Identification and characterization of chiroinositol-containing phospholipids from bovine liver.Biochem Biophys Res Commun. 1992 Apr 30;184(2):1042-7. doi: 10.1016/0006-291x(92)90696-i. Biochem Biophys Res Commun. 1992. PMID: 1575723
-
Assay of insulin mediator activity with soluble pyruvate dehydrogenase phosphatase.Endocrinology. 1985 May;116(5):1912-9. doi: 10.1210/endo-116-5-1912. Endocrinology. 1985. PMID: 2985364
-
Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo.Endocrinology. 1993 Feb;132(2):652-7. doi: 10.1210/endo.132.2.8425485. Endocrinology. 1993. PMID: 8425485
-
Isolation, structure, synthesis, and bioactivity of a novel putative insulin mediator. A galactosamine chiro-inositol pseudo-disaccharide Mn2+ chelate with insulin-like activity.J Med Chem. 2003 Jul 17;46(15):3283-91. doi: 10.1021/jm030071j. J Med Chem. 2003. PMID: 12852758
-
Insulin mediator causes dephosphorylation of the alpha subunit of pyruvate dehydrogenase by stimulating phosphatase activity.Arch Biochem Biophys. 1985 Feb 15;237(1):142-50. doi: 10.1016/0003-9861(85)90263-2. Arch Biochem Biophys. 1985. PMID: 2982326
Cited by
-
Inositolphosphoglycans are possible mediators of the glucagon-like peptide 1 (7-36)amide action in the liver.J Endocrinol Invest. 1996 Feb;19(2):114-8. doi: 10.1007/BF03349846. J Endocrinol Invest. 1996. PMID: 8778163
-
Genetic modification of Bacillus subtilis for production of D-chiro-inositol, an investigational drug candidate for treatment of type 2 diabetes and polycystic ovary syndrome.Appl Environ Microbiol. 2006 Feb;72(2):1310-5. doi: 10.1128/AEM.72.2.1310-1315.2006. Appl Environ Microbiol. 2006. PMID: 16461681 Free PMC article.
-
Glycosylphosphatidylinositol (GPI) hydrolysis by transforming growth factor-beta1 (TGF-beta1) as a potential early step in the inhibition of epithelial cell proliferation.Mol Cell Biochem. 2000 May;208(1-2):143-50. doi: 10.1023/a:1007064211120. Mol Cell Biochem. 2000. PMID: 10939638
-
Diabetes and the role of inositol-containing lipids in insulin signaling.Mol Med. 1999 Aug;5(8):505-14. Mol Med. 1999. PMID: 10501653 Free PMC article. Review.
-
d- chiro-Inositol is absorbed but not synthesised in rodents.Br J Nutr. 2009 Nov;102(10):1426-34. doi: 10.1017/S0007114509990456. Epub 2009 Jul 9. Br J Nutr. 2009. PMID: 19586572 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical